Study Of Intraductal Carboplatin In Women With Ductal Carcinoma In Situ (DCIS)
Status: UNKNOWN
Study type: INTERVENTIONAL
Conditions: Ductal Carcinoma In Situ
Interventions: DRUG: Carboplatin i.d. Days 1 & 15|DRUG: Carboplatin i.d. Day 1; Normal Saline i.d. Day 15|DRUG: Normal Saline
Sponsor: Windy Hill Medical, Inc.